Answers are grounded in this paper and cite their sources.
Understanding the epidemiological characteristics of respiratory syncytial virus (RSV) prevalence is essential for developing effective public health interventions.This observational study analyzed 5,666 687 RSV surveillance records from Canada (WHO Global Influenza Programme, 2016-2025).Weekly and annual positivity rates were computed, and nine-year trends were visualized.Seasonal metrics including onset week, peak week, offset week and epidemic duration were quantified for each RSV season.In the pre-pandemic period (2016-2017 to 2019-2020), RSV seasonality varied annually in intensity and timing.The COVID-19 pandemic substantially disrupted RSV circulation: the 2020-2021 season yielded a positivity rate of 0.08% without a defined epidemic season, while 2021-2022 presented two waves with the earliest onset (week 33) and longest duration (29 weeks).For the post-non-pharmaceutical intervention (NPI) period (2023)(2024)(2024)(2025), RSV seasons showed earlier onset and offset with shorter durations.Although timing metrics shifted relative to pre-pandemic baselines, non-significant results should be interpreted cautiously owing to limited sample size of epidemic seasons.Aggregated pre-pandemic positivity (5.73%) was significantly higher than pandemic-era (4.85%) and post-NPI (3.98%) values.In conclusion, prior to the COVID-19 pandemic, RSV seasonality in Canada varied annually.The pandemic caused observable shifts in the onset, offset, and duration of RSV seasons.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: